BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7539075)

  • 1. Effect of the antiallergic drug disodium cromoglycate and various derivatives on alkaline phosphatase.
    Ochoa de Aspuru E; Lourdes Zatón AM
    J Enzyme Inhib; 1994; 8(2):87-95. PubMed ID: 7539075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the antiallergic drug disodium cromoglycate on phosphodiesterase activity.
    Ochoa de Aspuru E; Zatón AM
    J Enzyme Inhib; 1996; 10(2):135-9. PubMed ID: 8835938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological activity of biscoumarinoxy-, bis(1,2-benzisoxazoloxy) & bisbenzofuranoxy-alkanes & their unsymmetric compounds: disodium cromoglycate analogs.
    Thakar KA; Dumir AB
    Indian J Exp Biol; 1978 Jun; 16(6):732-4. PubMed ID: 81180
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel cell-permeable cromoglycate derivative inhibits type I Fc epsilon receptor mediated Ca2+ influx and mediator secretion in rat mucosal mast cells.
    Hemmerich S; Sijpkens D; Pecht I
    Biochemistry; 1991 Feb; 30(6):1523-32. PubMed ID: 1704255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of a new antiallergic agent, KP-136 on mast cell activation: a comparison with disodium cromoglycate.
    Kuriyama K; Hiyama Y; Ito K; Yoshinaka I; Bito Y
    Agents Actions; 1988 Dec; 25(3-4):321-5. PubMed ID: 3146215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of calcium ions in the mode of action of disodium cromoglycate and ketotifen on smooth muscle.
    Arruzazabala ML; González Alvarez R; Sarracent Pérez J
    Allergol Immunopathol (Madr); 1983; 11(1):15-8. PubMed ID: 6407289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of in vitro allogeneic reactions with disodium cromoglycate.
    McIntyre JA; Neerunjun ED; Faulk WP; Papamichail M
    Int Arch Allergy Appl Immunol; 1981; 66(3):244-50. PubMed ID: 6457805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disodium cromoglycate inhibition of substance P-induced histamine secretion is calcium dependent.
    Nishibori M; Saeki K
    Jpn J Pharmacol; 1983 Dec; 33(6):1255-61. PubMed ID: 6199541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disodium cromoglycate inhibits immunoglobulin production in vitro without affecting cell growth in human B cell lines.
    Kimata H; Yoshida A; Ishioka C; Mikawa H
    Int Arch Allergy Appl Immunol; 1990; 93(2-3):280-1. PubMed ID: 2129166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of disodium cromoglycate (DSCG) on the guinea pig trachea and ileum.
    González Alvarez R; Arruzazabala ML
    Allergol Immunopathol (Madr); 1983; 11(6):425-30. PubMed ID: 6422728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkaline phosphatase inhibition by a series of pyrido[2,1-b]quinazolines: A possible relationship with cromolyn-like antiallergy activity.
    Schwender CF; Sunday BR; Decker VL
    J Med Chem; 1982 Jun; 25(6):742-5. PubMed ID: 6808133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibitory effects of disodium cromoglycate on ionic transports involved in sickle cell dehydration.
    Bizumukama L; Ferster A; Gulbis B; Kumps A; Cotton F
    Pharmacology; 2009; 83(5):318-22. PubMed ID: 19401631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
    Khandwala A; Coutts SM; Dally-Meade V; Jariwala N; Huang FC
    Int Arch Allergy Appl Immunol; 1983; 70(4):311-20. PubMed ID: 6186610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiallergic activity of tetracyclic derivatives of quinoline-2-carboxylic acid. 2. Some benzothienoquinolinecarboxylic acids.
    Wade JJ; Erickson EH; Hegel RF; Lappi LR; Rice TK
    J Med Chem; 1978 Sep; 21(9):941-8. PubMed ID: 102797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of predosage with disodium cromoglycate (DSCG) on the dose-related inhibition of rat passive cutaneous anaphylaxis by DSCG.
    Riley PA; Sheard P; Clarke AJ; Orr TS
    Life Sci; 1975 Sep; 17(5):793-802. PubMed ID: 813078
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
    Eleno N; Gajate E; Macias J; Garay RP
    Pulm Pharmacol Ther; 1999; 12(1):55-60. PubMed ID: 10208836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of disodium cromoglycate on neutrophil movement and intracellular calcium mobilization.
    Skedinger MC; Augustine NH; Morris EZ; Nielson DW; Zimmerman GA; Hill HR
    J Allergy Clin Immunol; 1987 Oct; 80(4):573-7. PubMed ID: 3117863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disodium cromoglycate, DSCG].
    Weber R
    Med Monatsschr Pharm; 1985 Feb; 8(2):34-6. PubMed ID: 3920483
    [No Abstract]   [Full Text] [Related]  

  • 19. Current views of the mechanism of action of prophylactic antiallergic drugs.
    González Alvarez R; Arruzazabala ML
    Allergol Immunopathol (Madr); 1981; 9(6):501-8. PubMed ID: 6122370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
    Gonzalez Alvarez R; Kazimierczak W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):333-9. PubMed ID: 6135406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.